Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Baron Asset Fund rose 18.98% in Q2 2026, outperforming the Russell Midcap Growth Index by 443 basis points despite significant headwinds from Beta and Momentum factors that posted exceptional performance. The Fund's outperformance...
— Ron Baron
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Edwards Lifesciences Corp.